Cambridge Investment Research Advisors
RTO icon

Cambridge Investment Research Advisors’s Rentokil RTO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,206
Closed -$227K – 4164
2026
Q1 		$227K Sell
7,206
-757
-10% -$23.9K ﹤0.01% 3565
2025
Q4 		$235K Sell
7,963
-2,581
-24% -$71.7K ﹤0.01% 3436
2025
Q3 		$266K Sell
10,544
-2,371
-18% -$57.8K ﹤0.01% 3219
2025
Q2 		$310K Sell
12,915
-15
-0.1% -$348 ﹤0.01% 2949
2025
Q1 		$296K Buy
12,930
+3,993
+45% +$96.4K ﹤0.01% 2880
2024
Q4 		$226K Buy
+8,937
New +$226K ﹤0.01% 3090
2024
Q3 		– Sell
-15,103
Closed -$448K – 3516
2024
Q2 		$448K Buy
15,103
+886
+6% +$24.6K ﹤0.01% 2386
2024
Q1 		$429K Buy
+14,217
New +$394K ﹤0.01% 2401

Other funds holding RTO

Jupiter Topco
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Gates Capital Management
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
River Road Asset Management
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Snyder Capital Management
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
SL
Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Cambridge Investment Research Advisors's RTO Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of Rentokil (RTO) in Q2 2026, closing a stake of 7,206 shares — an estimated $227K sold.

Cambridge Investment Research Advisors first reported a position in RTO in Q1 2024 and held it in 8 quarters. The position peaked at $448K in Q2 2024. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Cambridge Investment Research Advisors reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 7,206 Rentokil shares in Q2 2026, an estimated $227K.
  • Cambridge Investment Research Advisors first reported a position in Rentokil in Q1 2024 and held it in 8 quarters.
  • Cambridge Investment Research Advisors's Rentokil position peaked at $448K in Q2 2024.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.